Catalyst Wire Dossier Catalyst Wire Dossier

Koselugo

selumetinib · AstraZeneca
Drug timelines are a Plus or Pro feature.

22 regulatory and trial events tracked for Koselugo, covering 2016-04-05 to 2026-07-01. Get the full timeline:

Most recent: EMA Authorised: Koselugo (selumetinib sulfate) — AstraZeneca AB

See pricing